Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance
Required Education:
PharmD
Additional Information:
2 openings available.
Employer will assist with relocation costs.
Pfizer Research & Development Groton, CT
Pfizer Inc., in conjunction with MCPHS, offers a unique two-year post-PharmD fellowship program in Global Clinical Supply (GCS) with a focus on Clinical Research Pharmacy.
Fellowship Overview
This two-year fellowship program provides a comprehensive post-doctoral experience that fosters professional growth and develops the necessary skills for a successful career in Research and Development in the biopharmaceutical industry. During their first year, fellows will receive in-depth training in each of the following GCS disciplines and participate in rotational modules throughout other areas within the drug development process:
Clinical Research Pharmacy
Clinical Supply Information Systems
Clinical Supply Operations
Clinical Supply Strategy and Management
Quality Assurance
In their second year, fellows will focus on projects within Clinical Research Pharmacy. Throughout the fellowship, the Global Clinical Supply fellows will be integral members of Pfizer’s Global Clinical Supply organization. The fellows will have the opportunity to gain valuable experience in key functional areas that set and operationalize the clinical supply strategy, systems, packaging/labeling, logistics, as well as provide instructions and training of investigational products (IP) in compliance with Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) standards.
About Pfizer
For 175 years, Pfizer has delivered breakthrough medicines that change patients’ lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of global medicines in Oncology, Vaccines, Anti-Infectives, Inflammation and Immunology, as well as Internal Medicine and Hospital.
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatment, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Application Procedure
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal (SMApply) will open up on Monday, October 7, 2024. Applicants must upload the following application materials to the online portal by Monday, November 4, 2024:
Letter of intent (addressed to the company specific program director/lead; found in each company brochure)
Curriculum vitae
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Three recommendation evaluation forms must be submitted no later than November 20, 2024 via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.
Application Review and Interview Timeline
Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.
ASHP Midyear and Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in New Orleans, LA. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location.
AIFA First Offer Date
The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than December 16, 2024. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.
We see this respect for candidate choice as a common aspect of each of our Program's cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline.
For more than 150 years, Pfizer has delivered breakthrough medicines that change patients’ lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of global medicines in Oncology, Vaccines, Rare Disease, Inflammation, and Immunology, as well as Internal Medicine and Hospital.
Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatment, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.